Titelia

Holdings of ACUTA CAPITAL PARTNERS, LLC

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
22 in 2 countries
Top ten
85.3 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1Praxis Precision Medicines Inc 84,90127.4M $
2Terns Pharmaceuticals Inc 495,77226.1M $
3Aadi Bioscience Inc 3,410,40211.8M $
4Tango Therapeutics Inc 441,8319.2M $
5Sutro Biopharma Inc 269,4256.7M $
6Erasca Inc 354,5755.7M $
7Surrozen Inc 172,8475M $
8Ocular Therapeutix Inc 592,1085M $
9Compass Therapeutics Inc 849,0764.5M $
10Minerva Neurosciences Inc 709,5004.3M $
11Argenx SE 4,6903.4M $
12Revolution Medicines Inc 26,0692.5M $
13Amylyx Pharmaceuticals Inc 151,0672.1M $
14Taysha Gene Therapies Inc 439,4642M $
15Ideaya Biosciences Inc 48,2341.6M $
16Design Therapeutics Inc 145,9001.6M $
17United Therapeutics Corp 2,2241.3M $
18Entrada Therapeutics Inc 89,3581.1M $
19AVALO THERAPEUTICS INC 60,808907.9K $
20LB Pharmaceuticals Inc 28,919713.1K $
21Maze Therapeutics Inc 19,335577.2K $
22Unicycive Therapeutics Inc 57,959381.4K $

Download this table: CSV, JSON

Sector breakdown

  • Health care 3.8 %
  • Unattributed 96.2 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • United States 97.2 %
  • Netherlands 2.8 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1United States21120.6M $97.24 %
2Netherlands13.4M $2.76 %
Cite this page

Titelia. "Holdings of ACUTA CAPITAL PARTNERS, LLC". https://titelia.com/en/funds/US13F1582844